Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond Genotype: Multidomain Biomarker-Integrated Risk Scores Reveal Prognostic phenotypes Among Individuals with High-Risk <i>APOL1</i> Genotypes.

medRxiv : the preprint server for health sciences·2026
Same author

Resolving the glycosaminoglycan signature of ischemic stroke brain using PRM-based IR-MALDESI mass spectrometry imaging.

Analytical and bioanalytical chemistry·2026
Same author

Acriflavine delivery via Polyurethane nanocapsules to treat neovascular age-related macular degeneration.

bioRxiv : the preprint server for biology·2026
Same author

Neutrophil lymphocyte ratio as a marker of skin disease activity in older children with juvenile dermatomyositis.

Pediatric rheumatology online journal·2025
Same author

A simple, efficient technique to make colon crypt gels for 3D models.

3D printing and additive manufacturing·2025
Same author

Association of disease-modifying antirheumatic drug selection with hospitalised infection among youth with childhood-onset systemic lupus erythematosus.

Lupus science & medicine·2025

Related Experiment Video

Updated: Oct 21, 2025

Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles
06:06

Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles

Published on: March 9, 2019

5.6K

Engineering PEGylated Polyester Nanoparticles to Reduce Complement-Mediated Infusion Reaction.

Nuzhat Maisha1, Nidhi Naik1, Mawuyon Okesola1

  • 1University of Maryland Baltimore County, Baltimore, MD Piscataway Territories 21250, United States.

Bioconjugate Chemistry
|September 9, 2021
PubMed
Summary

Modifying nanoparticle surfaces with polyethylene glycol (PEG) reduces dangerous complement activation. Higher molecular weight PEG (5000 Da) is more effective than lower molecular weight PEG (3400 Da) at preventing these immune responses.

More Related Videos

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.2K
Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery
10:38

Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery

Published on: January 15, 2018

12.8K

Related Experiment Videos

Last Updated: Oct 21, 2025

Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles
06:06

Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles

Published on: March 9, 2019

5.6K
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.2K
Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery
10:38

Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery

Published on: January 15, 2018

12.8K

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Immunology

Background:

  • Intravenous administration of nanomaterials is hindered by severe, life-threatening infusion reactions.
  • The complement activation pathway, part of the innate immune system, significantly mediates these adverse reactions.
  • Nanoparticle surface properties, particularly PEGylation, are crucial for evading immune detection and improving blood circulation.

Purpose of the Study:

  • To investigate how altering polyethylene glycol (PEG) density and architecture on nanoparticle surfaces impacts the complement response in vitro.
  • To assess the effect of varying PEG chain lengths on nanoparticle stealth properties.
  • To determine cytokine changes upon blood incubation with nanoparticles to understand inflammation and immune response crosstalk.

Main Methods:

  • Utilized block copolymers of poly(lactic acid)-b-poly(ethylene glycol) with PEG macroinitiators of 3400 Da and 5000 Da.
  • Monitored the complement biomarker C5a to assess complement activation.
  • Analyzed cytokine profiles to evaluate inflammatory responses and immune crosstalk.

Main Results:

  • Increased PEGylation of nanoparticle surfaces significantly reduced the generation of complement-mediated anaphylatoxin C5a in vitro.
  • Polyethylene glycol (PEG) with a molecular weight of 5000 Da demonstrated superior efficacy in reducing C5a levels compared to 3400 Da PEG.
  • Identified specific cytokine changes indicating the extent of inflammation and interplay between complement and immune responses.

Conclusions:

  • Modifying nanoparticle surface architecture by increasing PEG density and utilizing longer PEG chains (5000 Da) effectively suppresses complement activation.
  • These findings are critical for designing 'stealth' nanoparticles that minimize adverse infusion reactions for safer intravenous administration.
  • Understanding the impact of PEGylation on complement and immune responses paves the way for developing improved nanomedicines.